Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvie Quaranta

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Therapie|March 7, 2017
Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of PharmacogeneticsSylvie Quaranta, Fabienne Thomas
Therapie|August 9, 2011
[Evidence-based therapeutic drug monitoring for nevirapine]Patrice Muret, Sarah Piedoux, Caroline Solas, et al.
Annales De Biologie Clinique|August 15, 2014
[Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization]Simon Scodavolpe, Sylvie Quaranta, Bruno Lacarelle, et al.
Therapie|February 27, 2017
Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of PharmacogeneticsSylvie Quaranta, Julien Dupouey, Romain Colle, et al.
Therapie|February 13, 2017
Sylvie Quaranta, Julien Dupouey, Romain Colle, et al.
Therapie|July 10, 2016
[Not Available]Patrice Muret, Sarah Piedoux, Caroline Solas, et al.
Therapie|August 9, 2011
[Evidence-based therapeutic drug monitoring for ribavirine]Caroline Solas, Maxime Paré, Sylvie Quaranta, et al.
Annales De Biologie Clinique|October 23, 2014
[Clinical application, limits and perspectives of pharmacogenetic and pharmacokinetic analysis of anticancer drugs]Anne-Sophie Chantry, Sylvie Quaranta, Joseph Ciccolini, et al.
Therapie|July 10, 2016
[Not Available]Caroline Solas, Maxime Paré, Sylvie Quaranta, et al.
British Journal of Clinical Pharmacology|August 8, 2022
Renal impairment and DPD testing: Watch out for false-positive results!Laure Carriat, Sylvie Quaranta, Caroline Solas, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Therapie|March 7, 2017
Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of PharmacogeneticsSylvie Quaranta, Fabienne Thomas
Therapie|August 9, 2011
[Evidence-based therapeutic drug monitoring for nevirapine]Patrice Muret, Sarah Piedoux, Caroline Solas, et al.
Annales De Biologie Clinique|August 15, 2014
[Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization]Simon Scodavolpe, Sylvie Quaranta, Bruno Lacarelle, et al.
Therapie|February 27, 2017
Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of PharmacogeneticsSylvie Quaranta, Julien Dupouey, Romain Colle, et al.
Therapie|February 13, 2017
Sylvie Quaranta, Julien Dupouey, Romain Colle, et al.
Therapie|July 10, 2016
[Not Available]Patrice Muret, Sarah Piedoux, Caroline Solas, et al.
Therapie|August 9, 2011
[Evidence-based therapeutic drug monitoring for ribavirine]Caroline Solas, Maxime Paré, Sylvie Quaranta, et al.
Annales De Biologie Clinique|October 23, 2014
[Clinical application, limits and perspectives of pharmacogenetic and pharmacokinetic analysis of anticancer drugs]Anne-Sophie Chantry, Sylvie Quaranta, Joseph Ciccolini, et al.
Therapie|July 10, 2016
[Not Available]Caroline Solas, Maxime Paré, Sylvie Quaranta, et al.
British Journal of Clinical Pharmacology|August 8, 2022
Renal impairment and DPD testing: Watch out for false-positive results!Laure Carriat, Sylvie Quaranta, Caroline Solas, et al.
Pageof 4